AU8084594A - Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients - Google Patents

Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients

Info

Publication number
AU8084594A
AU8084594A AU80845/94A AU8084594A AU8084594A AU 8084594 A AU8084594 A AU 8084594A AU 80845/94 A AU80845/94 A AU 80845/94A AU 8084594 A AU8084594 A AU 8084594A AU 8084594 A AU8084594 A AU 8084594A
Authority
AU
Australia
Prior art keywords
dosage forms
active ingredients
aluminum silicate
magnesium aluminum
containing magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80845/94A
Other languages
English (en)
Inventor
Michelle Elizabeth Brideau
Anne Marie Carella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU8084594A publication Critical patent/AU8084594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU80845/94A 1993-10-28 1994-10-20 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients Abandoned AU8084594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14459293A 1993-10-28 1993-10-28
US144592 1993-10-28
PCT/US1994/012018 WO1995011671A1 (en) 1993-10-28 1994-10-20 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients

Publications (1)

Publication Number Publication Date
AU8084594A true AU8084594A (en) 1995-05-22

Family

ID=22509264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80845/94A Abandoned AU8084594A (en) 1993-10-28 1994-10-20 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients

Country Status (4)

Country Link
EP (1) EP0725630A1 (de)
JP (1) JPH09504293A (de)
AU (1) AU8084594A (de)
WO (1) WO1995011671A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3693397A (en) * 1996-07-10 1998-02-02 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
MY119059A (en) † 1997-08-11 2005-03-31 Cadbury Adams Usa Llc Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same
US7588793B1 (en) 1998-06-05 2009-09-15 Cadbury Adams Usa, Llc Enhanced flavoring compositions containing N-ethyl-p-menthane-3-carboxamide and method of making and using same
AU767154B2 (en) * 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US8097271B2 (en) 2004-08-11 2012-01-17 Kraft Foods Global Brands Llc Warming compositions and delivery systems therefor
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
EP1973422B1 (de) 2005-12-23 2014-06-11 Intercontinental Great Brands LLC Zusammensetzungen für die orale oder dermale abgabe, die ein wärmegefühl vermitteln
SG173537A1 (en) 2009-04-01 2011-09-29 Colgate Palmolive Co Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
ES2656944T3 (es) 2011-04-29 2018-03-01 Intercontinental Great Brands Llc Ácido encapsulado, método de preparación del mismo, y goma de mascar que lo comprende

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
ATE128351T1 (de) * 1991-04-04 1995-10-15 Procter & Gamble Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
JPH09504293A (ja) 1997-04-28
WO1995011671A1 (en) 1995-05-04
EP0725630A1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
HUT75648A (en) 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
IL110834A0 (en) Carboxamides, their preparation and pharmaceutical compositions containing them
AU3373293A (en) Anthraquinone compounds and pharmaceutical compositions containing them
AU7961094A (en) Picosulphate dosage form
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
AU8084594A (en) Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU5643894A (en) Novel esculetin derivatives and pharmaceutical composition
AU3465393A (en) Pharmaceutic composition and its use
AU4513893A (en) Sulfamoyltriazole derivative and bactericide containing the same as active ingredient
IL108810A0 (en) Optical isomerization inhibitor and pharmaceutical compositions containing the same
AU3526193A (en) Dosage aerosols containing the active substance flezelastin and related structures
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
NZ269990A (en) Inhibiting hiv viruses; use of azaspirane compounds in preparation of medicaments
AU6345794A (en) Ipsapirone medicament formulation
ZA935862B (en) New hydrazono-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
AU6426994A (en) Aluminium containing pharmaceutical preparation with controlled release
AU2875692A (en) Easily stored pillow and blanket
HUT73481A (en) Tropane-derivates having analgesic and nootropic effect and pharmaceutical compositions containing the same
AU7292594A (en) Peelable barrier overwrap package
AU6208594A (en) Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
AU8108394A (en) Pharmaceutical composition and use thereof